HomeInsightsPE

Aarey Drugs & Pharmaceuticals Ltd PE Ratio

Aarey Drugs & Pharmaceuticals Ltd PE Ratio

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Dec 12, 2024)

stocks purchased

0.9 K

Stocks Traded

(Dec 12, 2024)

Last Updated on: Dec 12, 2024

Image

Aarey Drugs & Pharmaceuticals Ltd

NSE: AAREYDRUGS

PE

24.7

Last updated on: Dec 12, 2024

Key Highlights

  • The P/E Ratio of Aarey Drugs & Pharmaceuticals Ltd is 24.7 as of 12 Dec 15:30 PM .
  • The P/E Ratio of Aarey Drugs & Pharmaceuticals Ltd changed from 10.3 on March 2019 to 26.8 on March 2024 . This represents a CAGR of 17.28% over 6 years.
  • The Latest Trading Price of Aarey Drugs & Pharmaceuticals Ltd is ₹ 61 as of 12 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.5. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Aarey Drugs & Pharmaceuticals Ltd

No data available

Company Fundamentals for Aarey Drugs & Pharmaceuticals Ltd

No data available

Image

Aarey Drugs & Pharmaceuticals Ltd

NSE: AAREYDRUGS

Share Price

₹ 61

0.00 (0.00%)

stock direction

Last updated on: Dec 12, 2024

Market Price of Aarey Drugs & Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Aarey Drugs & Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
12 Dec 202461
11 Dec 202461
10 Dec 202461.75
09 Dec 202462.37
06 Dec 202461.15
05 Dec 202462.3
04 Dec 202463.13
03 Dec 202463.43
02 Dec 202462.23
29 Nov 202460.16

SWOT Analysis Of Aarey Drugs & Pharmaceuticals Ltd

Strength

0

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Aarey Drugs & Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Aarey Drugs & Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Aarey Drugs & Pharmaceuticals Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Aarey Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Aarey Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Aarey Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Aarey Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payout of Aarey Drugs & Pharmaceuticals Ltd

No data available

* All values are in %

About Aarey Drugs & Pharmaceuticals Ltd

  • Aarey Drugs & Pharmaceuticals Ltd was originally incorporated on May 15, 1990 as a private limited company in Mumbai with the name Niharika Textiles & Chemicals Pvt Ltd. The company was originally promoted by Prakash Mandhana, Kavita Mandhana and Neeta Mandhana.
  • In March, 1993, the Aarey Group of companies belonging to Ghatalia family took over the company and the company was converted into public limited company.
  • Also, the name of the company was changed from Niharika Textiles & Chemicals Pvt Ltd to Aarey Drugs & Pharmaceuticals Ltd. The Company is one of the manufacturer and suppliers of pharmaceutical raw materials, Chemicals, Pharmaceuticals ingredients, API's Drugs, Food Colours and Flavours.
  • The company is engaged in the business of manufacturing, selling of drugs & pharmaceutical products and is governed by a number of central and state legislations that regulate the business.

Aarey Drugs & Pharmaceuticals Ltd News Hub

News

Aarey Drugs & Pharmaceuticals standalone net profit rises 72.22% in the June 2024 quarter

Net profit of Aarey Drugs & Pharmaceuticals rose 72.22% to Rs 1.24 crore in the quarter en...

Read more

2024-08-16 00:00:00

News

Aarey Drugs & Pharmaceuticals to hold board meeting

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

2024-08-10 00:00:00

News

Aarey Drugs & Pharmaceuticals schedules AGM

Aarey Drugs & Pharmaceuticals announced that the 34th Annual General Meeting (AGM) of the ...

Read more

2024-09-19 00:00:00

News

Aarey Drugs & Pharmaceuticals to conduct board meeting

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

2024-09-25 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Aarey Drugs & Pharmaceuticals Ltd

What is the current PE Ratio of Aarey Drugs & Pharmaceuticals Ltd?

The Current PE Ratio of Aarey Drugs & Pharmaceuticals Ltd is 24.7 as on 12 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 12 Dec 2024.

What was the PE Ratio of Aarey Drugs & Pharmaceuticals Ltd last year?

The PE Ratio of Aarey Drugs & Pharmaceuticals Ltd was 15.89 last year, now the PE ratio is 24.7, showing a year-on-year growth of 55.4%.

What does the PE Ratio of Aarey Drugs & Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Aarey Drugs & Pharmaceuticals Ltd is 24.7. This ratio indicates that investors are willing to pay 24.7 times the earnings per share for each share of Aarey Drugs & Pharmaceuticals Ltd.

What is the PE Ratio Growth of Aarey Drugs & Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Aarey Drugs & Pharmaceuticals Ltd grew by 55.4% whereas, the EPS ratio grew by 29.5.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions